ISLAND PHARMACEUTICALS LIMITED - Announcements

Market Cap $17.92M Add to my watchlist

Healthcare

Island Pharmaceuticals Limited is an Australia-based drug repurposing company, focused on... Island Pharmaceuticals Limited is an Australia-based drug repurposing company, focused on areas of need for antiviral therapeutics to address infectious diseases. The Company's lead asset is ISLA-101, a drug, being repurposed for the prevention and treatment of dengue fever and other mosquito (or vector) borne diseases. ISLA-101 has been shown to have activity against all four strains of dengue virus as well as other flaviviruses such as Zika virus, West Nile virus, and Yellow Fever virus, as well as Chikungunya virus. The Company operates a single segment, being research and development activities principally in the geographic regions of Australia and the United States. Its subsidiary is Isla Pharmaceuticals Inc.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

ILA	Quarterly Activities & Cashflow Report	PRICE SENSITIVE	31/10/24	359.76KB	Share
ILA	Application for quotation of securities - ILA		30/10/24	15.51KB	Share
ILA	Application for quotation of securities - ILA		23/10/24	15.51KB	Share
ILA	Letter to Shareholders, Notice of AGM & Proxy Form		18/10/24	511.17KB	Share
ILA	Application for quotation of securities - ILA		16/10/24	15.51KB	Share
ILA	Becoming a substantial holder		15/10/24	318.48KB	Share
ILA	Change in substantial holding		15/10/24	241.46KB	Share
ILA	Change in substantial holding		15/10/24	272.03KB	Share
ILA	Becoming a substantial holder		15/10/24	651.77KB	Share
ILA	Cleansing Notice		11/10/24	191.25KB	Share
ILA	Application for quotation of securities - ILA		11/10/24	16.08KB	Share
ILA	Application for quotation of securities - ILA		09/10/24	15.5KB	Share
ILA	Investor presentation		08/10/24	2.04MB	Share
ILA	Investor webinar		04/10/24	150.12KB	Share
ILA	Proposed issue of securities - ILA		03/10/24	21.96KB	Share
ILA	Island completes $3.5m Placement	PRICE SENSITIVE	03/10/24	211.23KB	Share
ILA	Phase 2a PROTECT clinical trial dosed & Investor webinar	PRICE SENSITIVE	03/10/24	164.14KB	Share
ILA	Trading Halt	PRICE SENSITIVE	01/10/24	212.16KB	Share
ILA	Final Director's Interest Notice - DB		23/09/24	250.67KB	Share
ILA	Initial Director's Interest Notice - CN		23/09/24	229.16KB	Share
ILA	Investor presentation		19/09/24	1.59MB	Share
ILA	Board changes		19/09/24	157.89KB	Share
ILA	Application for quotation of securities - ILA		18/09/24	15.51KB	Share
ILA	Binding LOI for proposed acquisition of Galidesivir	PRICE SENSITIVE	11/09/24	206.67KB	Share
ILA	Appendix 4G and Corporate Governance Statement		29/08/24	546KB	Share
ILA	Annual Report to shareholders		29/08/24	3.22MB	Share
ILA	Preliminary Final Report	PRICE SENSITIVE	29/08/24	219.38KB	Share
ILA	Phase 2a/b clinical trial update	PRICE SENSITIVE	27/08/24	202.81KB	Share
ILA	ISLA-101 Phase 2a/b clinical trial progresses	PRICE SENSITIVE	07/08/24	896.87KB	Share
ILA	Application for quotation of securities - ILA		07/08/24	15.5KB	Share
ILA	Quarterly Activities & Cashflow Report	PRICE SENSITIVE	31/07/24	366.17KB	Share
ILA	Resignation of Joint Company Secretary		19/07/24	136.75KB	Share
ILA	Investor Presentation - Bioshares		10/07/24	1.86MB	Share
ILA	ISLA-101 Clinical Program Update		03/07/24	157.78KB	Share
ILA	Non-binding term sheet signed with BioCryst	PRICE SENSITIVE	03/07/24	196.42KB	Share
ILA	Trading Halt	PRICE SENSITIVE	01/07/24	561.07KB	Share
ILA	Change of Director Interest Notice - DF		26/06/24	197.57KB	Share
ILA	Application for quotation of securities - ILA		26/06/24	15.5KB	Share
ILA	Change in substantial holding		21/06/24	269.68KB	Share
ILA	Application for quotation of securities - ILA		21/06/24	16.31KB	Share
ILA	Application for quotation of securities - ILA		19/06/24	15.69KB	Share
ILA	Application for quotation of securities - ILA		12/06/24	15.68KB	Share
ILA	Piggy Back Options Closing Date Reminder		06/06/24	190.44KB	Share
ILA	Notification regarding unquoted securities - ILA		06/06/24	18.66KB	Share
ILA	Application for quotation of securities - ILA		05/06/24	15.65KB	Share
ILA	Investor Presentation	PRICE SENSITIVE	03/06/24	3.05MB	Share
ILA	New data leads to proposed ISLA-101 Phase 2 efficiencies	PRICE SENSITIVE	03/06/24	652.16KB	Share
ILA	Application for quotation of securities - ILA		29/05/24	15.65KB	Share
ILA	Grant funding to directly support Phase 2a trial	PRICE SENSITIVE	08/05/24	160.75KB	Share
ILA	Change of Director's Interest Notice x5		06/05/24	300.96KB	Share
ILA	Notification of cessation of securities - ILA		06/05/24	17.29KB	Share
ILA	Quarterly Appendix 4C and Activities Report	PRICE SENSITIVE	30/04/24	344.34KB	Share
ILA	Investor Presentation - Asia Bio Partnering	PRICE SENSITIVE	22/04/24	2.71MB	Share
ILA	Application for quotation of securities - ILA		17/04/24	15.78KB	Share
ILA	Positive data from ISLA-101 Single Ascending Dose study	PRICE SENSITIVE	16/04/24	148.54KB	Share
ILA	Change in substantial holding		04/04/24	109.91KB	Share
ILA	Change in substantial holding		04/04/24	128.46KB	Share
ILA	Change of Director's Interest Notice x 5		04/04/24	288.98KB	Share
ILA	Change in substantial holding		03/04/24	269.95KB	Share
ILA	Top 20 Option Holders & Distribution Schedule		02/04/24	83.38KB	Share
ILA	Security Class Reinstatement to Quotation ILAO	PRICE SENSITIVE	02/04/24	86.14KB	Share
ILA	Updated Trading Policy		27/03/24	245.2KB	Share
ILA	Application for quotation of securities - ILA		27/03/24	16.97KB	Share
ILA	Security Class Suspension from Quotation ILAO	PRICE SENSITIVE	26/03/24	88.32KB	Share
ILA	Application for quotation of securities - ILA		26/03/24	17.19KB	Share
ILA	Update - Proposed issue of securities - ILA		21/03/24	26.18KB	Share
ILA	Results of Rights Issue Offer		19/03/24	81.62KB	Share
ILA	Despatch of Rights Issue documentation		05/03/24	137.83KB	Share
ILA	Letter to ineligible shareholders		05/03/24	138.32KB	Share
ILA	Update - Proposed issue of securities - ILA		26/02/24	26.03KB	Share
ILA	Letter to Optionholders		26/02/24	211.33KB	Share
ILA	Letter to Eligible Shareholders		26/02/24	220.9KB	Share
ILA	Target Market Determination		26/02/24	163.42KB	Share
ILA	Proposed issue of securities - ILA		26/02/24	26.38KB	Share
ILA	Prospectus	PRICE SENSITIVE	26/02/24	668.63KB	Share
ILA	$1.95million Fully Underwritten Rights Issue	PRICE SENSITIVE	26/02/24	142.84KB	Share
ILA	Appendix 4D & Half-Year Financial Statements	PRICE SENSITIVE	26/02/24	662.68KB	Share
ILA	Trading Halt	PRICE SENSITIVE	22/02/24	201.6KB	Share
ILA	Island investor presentation	PRICE SENSITIVE	06/02/24	1.84MB	Share
ILA	Dosing complete in ISLA-101 SAD study	PRICE SENSITIVE	06/02/24	144.44KB	Share
ILA	Quarterly Activity Report and Appendix 4C	PRICE SENSITIVE	31/01/24	321.21KB	Share
ILA	Third cohort dosed in ISLA-101 Single Ascending Dose study	PRICE SENSITIVE	19/01/24	144.49KB	Share
ILA	Notification of cessation of securities - ILA		11/01/24	21.71KB	Share
ILA	Approval to commence dosing 3rd cohort of ISLA-101 SAD study	PRICE SENSITIVE	22/12/23	147.24KB	Share
ILA	R&D Tax Incentive loan facility secured with Radium Capital	PRICE SENSITIVE	15/12/23	146.24KB	Share
ILA	Second cohort dosed in ISLA-101 Single Ascending Dose study	PRICE SENSITIVE	12/12/23	111.58KB	Share
ILA	Company Secretary Appointment/Resignation		01/12/23	98.44KB	Share
ILA	Island doses first cohort in ISLA-101 clinical trial	PRICE SENSITIVE	24/11/23	118.71KB	Share
ILA	Replacement Constitution		16/11/23	424.03KB	Share
ILA	Replacement - Results of AGM		16/11/23	118.61KB	Share
ILA	Results of AGM		16/11/23	136.46KB	Share
ILA	Annual General Meeting MD Presentation		16/11/23	1.82MB	Share
ILA	Screening commences for ISLA-101 Single Ascending Dose Study	PRICE SENSITIVE	13/11/23	115.02KB	Share
ILA	Island receives R&D tax refund for FY2023	PRICE SENSITIVE	10/11/23	111.26KB	Share
ILA	Island receives ethics approval for ISLA-101 study	PRICE SENSITIVE	07/11/23	119.99KB	Share
ILA	ILA releases updated investor presentation		06/11/23	1.9MB	Share
ILA	ILA granted key Australian patent for ISLA-101	PRICE SENSITIVE	02/11/23	119.48KB	Share
ILA	Island Annual General Meeting online link for shareholders		31/10/23	95.45KB	Share
ILA	Quarterly Activity Report & Appendix 4C	PRICE SENSITIVE	30/10/23	323.65KB	Share
ILA	Annual Report to Shareholders		13/10/23	3.21MB	Share

ILA Quarterly Activities & Cashflow Report
31/10/24	PRICE SENSITIVE	359.76KB	Share
ILA Application for quotation of securities - ILA
30/10/24		15.51KB	Share
ILA Application for quotation of securities - ILA
23/10/24		15.51KB	Share
ILA Letter to Shareholders, Notice of AGM & Proxy Form
18/10/24		511.17KB	Share
ILA Application for quotation of securities - ILA
16/10/24		15.51KB	Share
ILA Becoming a substantial holder
15/10/24		318.48KB	Share
ILA Change in substantial holding
15/10/24		241.46KB	Share
ILA Change in substantial holding
15/10/24		272.03KB	Share
ILA Becoming a substantial holder
15/10/24		651.77KB	Share
ILA Cleansing Notice
11/10/24		191.25KB	Share
ILA Application for quotation of securities - ILA
11/10/24		16.08KB	Share
ILA Application for quotation of securities - ILA
09/10/24		15.5KB	Share
ILA Investor presentation
08/10/24		2.04MB	Share
ILA Investor webinar
04/10/24		150.12KB	Share
ILA Proposed issue of securities - ILA
03/10/24		21.96KB	Share
ILA Island completes $3.5m Placement
03/10/24	PRICE SENSITIVE	211.23KB	Share
ILA Phase 2a PROTECT clinical trial dosed & Investor webinar
03/10/24	PRICE SENSITIVE	164.14KB	Share
ILA Trading Halt
01/10/24	PRICE SENSITIVE	212.16KB	Share
ILA Final Director's Interest Notice - DB
23/09/24		250.67KB	Share
ILA Initial Director's Interest Notice - CN
23/09/24		229.16KB	Share
ILA Investor presentation
19/09/24		1.59MB	Share
ILA Board changes
19/09/24		157.89KB	Share
ILA Application for quotation of securities - ILA
18/09/24		15.51KB	Share
ILA Binding LOI for proposed acquisition of Galidesivir
11/09/24	PRICE SENSITIVE	206.67KB	Share
ILA Appendix 4G and Corporate Governance Statement
29/08/24		546KB	Share
ILA Annual Report to shareholders
29/08/24		3.22MB	Share
ILA Preliminary Final Report
29/08/24	PRICE SENSITIVE	219.38KB	Share
ILA Phase 2a/b clinical trial update
27/08/24	PRICE SENSITIVE	202.81KB	Share
ILA ISLA-101 Phase 2a/b clinical trial progresses
07/08/24	PRICE SENSITIVE	896.87KB	Share
ILA Application for quotation of securities - ILA
07/08/24		15.5KB	Share
ILA Quarterly Activities & Cashflow Report
31/07/24	PRICE SENSITIVE	366.17KB	Share
ILA Resignation of Joint Company Secretary
19/07/24		136.75KB	Share
ILA Investor Presentation - Bioshares
10/07/24		1.86MB	Share
ILA ISLA-101 Clinical Program Update
03/07/24		157.78KB	Share
ILA Non-binding term sheet signed with BioCryst
03/07/24	PRICE SENSITIVE	196.42KB	Share
ILA Trading Halt
01/07/24	PRICE SENSITIVE	561.07KB	Share
ILA Change of Director Interest Notice - DF
26/06/24		197.57KB	Share
ILA Application for quotation of securities - ILA
26/06/24		15.5KB	Share
ILA Change in substantial holding
21/06/24		269.68KB	Share
ILA Application for quotation of securities - ILA
21/06/24		16.31KB	Share
ILA Application for quotation of securities - ILA
19/06/24		15.69KB	Share
ILA Application for quotation of securities - ILA
12/06/24		15.68KB	Share
ILA Piggy Back Options Closing Date Reminder
06/06/24		190.44KB	Share
ILA Notification regarding unquoted securities - ILA
06/06/24		18.66KB	Share
ILA Application for quotation of securities - ILA
05/06/24		15.65KB	Share
ILA Investor Presentation
03/06/24	PRICE SENSITIVE	3.05MB	Share
ILA New data leads to proposed ISLA-101 Phase 2 efficiencies
03/06/24	PRICE SENSITIVE	652.16KB	Share
ILA Application for quotation of securities - ILA
29/05/24		15.65KB	Share
ILA Grant funding to directly support Phase 2a trial
08/05/24	PRICE SENSITIVE	160.75KB	Share
ILA Change of Director's Interest Notice x5
06/05/24		300.96KB	Share
ILA Notification of cessation of securities - ILA
06/05/24		17.29KB	Share
ILA Quarterly Appendix 4C and Activities Report
30/04/24	PRICE SENSITIVE	344.34KB	Share
ILA Investor Presentation - Asia Bio Partnering
22/04/24	PRICE SENSITIVE	2.71MB	Share
ILA Application for quotation of securities - ILA
17/04/24		15.78KB	Share
ILA Positive data from ISLA-101 Single Ascending Dose study
16/04/24	PRICE SENSITIVE	148.54KB	Share
ILA Change in substantial holding
04/04/24		109.91KB	Share
ILA Change in substantial holding
04/04/24		128.46KB	Share
ILA Change of Director's Interest Notice x 5
04/04/24		288.98KB	Share
ILA Change in substantial holding
03/04/24		269.95KB	Share
ILA Top 20 Option Holders & Distribution Schedule
02/04/24		83.38KB	Share
ILA Security Class Reinstatement to Quotation ILAO
02/04/24	PRICE SENSITIVE	86.14KB	Share
ILA Updated Trading Policy
27/03/24		245.2KB	Share
ILA Application for quotation of securities - ILA
27/03/24		16.97KB	Share
ILA Security Class Suspension from Quotation ILAO
26/03/24	PRICE SENSITIVE	88.32KB	Share
ILA Application for quotation of securities - ILA
26/03/24		17.19KB	Share
ILA Update - Proposed issue of securities - ILA
21/03/24		26.18KB	Share
ILA Results of Rights Issue Offer
19/03/24		81.62KB	Share
ILA Despatch of Rights Issue documentation
05/03/24		137.83KB	Share
ILA Letter to ineligible shareholders
05/03/24		138.32KB	Share
ILA Update - Proposed issue of securities - ILA
26/02/24		26.03KB	Share
ILA Letter to Optionholders
26/02/24		211.33KB	Share
ILA Letter to Eligible Shareholders
26/02/24		220.9KB	Share
ILA Target Market Determination
26/02/24		163.42KB	Share
ILA Proposed issue of securities - ILA
26/02/24		26.38KB	Share
ILA Prospectus
26/02/24	PRICE SENSITIVE	668.63KB	Share
ILA $1.95million Fully Underwritten Rights Issue
26/02/24	PRICE SENSITIVE	142.84KB	Share
ILA Appendix 4D & Half-Year Financial Statements
26/02/24	PRICE SENSITIVE	662.68KB	Share
ILA Trading Halt
22/02/24	PRICE SENSITIVE	201.6KB	Share
ILA Island investor presentation
06/02/24	PRICE SENSITIVE	1.84MB	Share
ILA Dosing complete in ISLA-101 SAD study
06/02/24	PRICE SENSITIVE	144.44KB	Share
ILA Quarterly Activity Report and Appendix 4C
31/01/24	PRICE SENSITIVE	321.21KB	Share
ILA Third cohort dosed in ISLA-101 Single Ascending Dose study
19/01/24	PRICE SENSITIVE	144.49KB	Share
ILA Notification of cessation of securities - ILA
11/01/24		21.71KB	Share
ILA Approval to commence dosing 3rd cohort of ISLA-101 SAD study
22/12/23	PRICE SENSITIVE	147.24KB	Share
ILA R&D Tax Incentive loan facility secured with Radium Capital
15/12/23	PRICE SENSITIVE	146.24KB	Share
ILA Second cohort dosed in ISLA-101 Single Ascending Dose study
12/12/23	PRICE SENSITIVE	111.58KB	Share
ILA Company Secretary Appointment/Resignation
01/12/23		98.44KB	Share
ILA Island doses first cohort in ISLA-101 clinical trial
24/11/23	PRICE SENSITIVE	118.71KB	Share
ILA Replacement Constitution
16/11/23		424.03KB	Share
ILA Replacement - Results of AGM
16/11/23		118.61KB	Share
ILA Results of AGM
16/11/23		136.46KB	Share
ILA Annual General Meeting MD Presentation
16/11/23		1.82MB	Share
ILA Screening commences for ISLA-101 Single Ascending Dose Study
13/11/23	PRICE SENSITIVE	115.02KB	Share
ILA Island receives R&D tax refund for FY2023
10/11/23	PRICE SENSITIVE	111.26KB	Share
ILA Island receives ethics approval for ISLA-101 study
07/11/23	PRICE SENSITIVE	119.99KB	Share
ILA ILA releases updated investor presentation
06/11/23		1.9MB	Share
ILA ILA granted key Australian patent for ISLA-101
02/11/23	PRICE SENSITIVE	119.48KB	Share
ILA Island Annual General Meeting online link for shareholders
31/10/23		95.45KB	Share
ILA Quarterly Activity Report & Appendix 4C
30/10/23	PRICE SENSITIVE	323.65KB	Share
ILA Annual Report to Shareholders
13/10/23		3.21MB	Share

REFRESH

1 2 3

(20min delay)
Last 11.5¢		Change -0.005(4.17%)		Mkt cap ! $17.92M

Open	High	Low	Value	Volume
12.0¢	12.0¢	11.5¢	$22.33K	186.1K

Buyers (Bids)

No.	Vol.	Price($)
2	87352	11.5¢

Sellers (Offers)

Price($)	Vol.	No.
12.0¢	23801	1

View Market Depth

No.	Vol.	Price($)
1	40000	0.115
2	10270	0.110
5	349999	0.100
1	250000	0.095
2	34151	0.090

Price($)	Vol.	No.
0.120	23801	1
0.125	39924	2
0.135	18647	1
0.150	6788	1
0.160	28373	2

Last trade - 15.31pm 01/11/2024 (20 minute delay)


Last 12.0¢		Change -0.005 ( 4.00 %)
Open	High	Low	Volume
12.0¢	12.0¢	12.0¢	40923
Last updated 12.10pm 01/11/2024 ?

ILA (ASX) Chart

ISLAND PHARMACEUTICALS LIMITED - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available